4016.SR

Middle East Pharmaceutical Industries Company 4016.SR

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 4016.SR 2070.SR 9592.SR 4014.SR 4163.SR 9546.SR 9527.SR 4009.SR 9518.SR 9600.SR
6M -7.28 % 8.63 % -4.90 % -14.23 % -34.14 % -26.75 % -23.91 % -43.57 % 30.59 % -8.19 %
YTD -1.95 % 2.98 % -0.67 % -0.06 % -1.28 % -5.00 % 7.80 % -0.36 % 30.03 % -2.41 %
1Y -12.34 % -21.34 % -4.68 % -37.24 % -37.44 % -44.12 % -13.79 % -56.27 % 25.69 % -11.43 %
3Y 3.94 % 14.74 % -7.38 % -26.43 % -32.46 % 58.49 % 196.61 % 24.87 % 87.37 % 31.75 %
5Y 3.94 % -30.48 % -7.38 % -28.29 % -36.32 % 35.44 % 61.54 % -4.40 % 78.50 % 31.75 %
10Y 3.94 % 12.48 % -7.38 % -28.29 % -36.32 % 35.44 % 61.54 % -53.25 % 78.50 % 31.75 %
From the beginning 3.94 % 28.39 % -7.38 % -28.29 % -36.32 % 35.44 % 61.54 % -53.25 % 78.50 % 31.75 %

Dividend

Middle East Pharmaceutical Industries Company

Saudi Pharmaceutical Industries and Medical Appliances Corporation

Scientific and Medical Equipment House Company

Al-Dawaa Medical Services Company

Naba Alsaha Medical Services Company

Ame Company For Medical Supplies

Middle East Healthcare Company

Canadian General Medical Center Complex Company